18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Clinical trial NCT06233903 · WITHDRAWN

Trial details

NCT number: NCT06233903
Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Pheochromocytoma Paraganglioma

Start date: 2025-01-01
Primary completion: 2025-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.